Filing Flows › Zimmer Biomet Holdings (ZBH) › Q3 2026
Zimmer Biomet Holdings (ZBH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 4, 2026
Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the third quarter 2026 (Q3 2026), +3% from a year earlier and -5% from the quarter before. Operating margin was 14.9%, net earnings $193M (9.4% of revenue).
Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1B | -5% | +3% |
| Operating profit | $308M | -6% | -12% |
| Net earnings | $193M | -3% | -17% |
| Operating cash flow | $560M | +25% | +34% |
| Free cash flow | $372M | — | +34% |
What changed
Revenue was $2.1B in Q3 2026, up 3% year over year and down 5% from the previous quarter. Knees was the largest line at 37% of revenue. SET added $0.04B year over year (up 7%), 60% of the total change. Knees declined 3%.
Operating profit was $0.31B, a 14.9% margin (down 2.6 points year over year). Operating profit fell $0.04B even though revenue rose $0.06B versus Q3 2025, so costs grew faster than sales. Total costs grew 6% against revenue growth of 3%. The fastest-growing cost line was Other operating costs (+22%). Net earnings were $0.19B, down 17% year over year. The effective tax rate was 16.2%.
Operating cash flow was $0.56B (up 34% year over year), 290% of net earnings. Non-cash charges added back $0.28B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.06B. After itions to instruments ($0.11B) and itions to other property, plant and equipment ($0.08B), free cash flow as the company reports it was $0.37B.
Questions
What was Zimmer Biomet Holdings' revenue in the third quarter 2026?
Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the third quarter 2026 (Q3 2026), +3% from a year earlier and -5% from the quarter before.
Was Zimmer Biomet Holdings profitable in the third quarter 2026?
Operating profit was $308M (14.9% of revenue) and net earnings $193M.